Cleantech Co. Advances Antimicrobial Wound Care Breakthrough
Source: Streetwise Reports  (10/17/25)
Cleantech innovation company BioLargo Inc. (BLGO:OTCQX) announced that subsidiary Clyra Medical Technologies is making significant strides. Read why one analyst says the technology is on "the cusp of commercialization." More >

Biotech Battles FDA, Target Price Shows Potential 90% Gains
Source: Dr. Boobalan Pachaiyappan  (10/1/25)
Capricor Therapeutics Inc. (CAPR:NASDAQ) has recently been involved in a "tug-of-war with the FDA." Read on to see why one Roth analyst still rates this stock as a Buy. More >

AI Healthcare Stock Showing Signs of a Base Breakout
Source: John Newell  (8/25/25)
John Newell of John Newell & Associates explains why he thinks Rocket Doctor AI (AIDR:CSE; TREIF:OTC; 939:FRA) is a Speculative Buy. More >

Co.'s Graphene Used in New Screening Test for Lung Cancer
Source: Streetwise Reports  (8/18/25)
HydroGraph Clean Power Inc.'s (HG:CSE; HGRAF:OTCQB; M98:FSE) patented, high-purity material has applications in healthcare, as in this case, but also in numerous other industries. Read on to learn why some experts say this company could be a future 100-bagger. More >

Biotech Firm Adjusts Placement Terms to Fuel U.S. Expansion
Source: Streetwise Reports  (7/7/25)
Canadian healthcare and clinical stage drug development company Algernon Pharmaceuticals Inc. (AGN:CSE; AGNPF:OTCQB; AGW0:XFRA) updates the pricing and warrant terms for its previously announced non-brokered private placement. Read why one technical analyst thinks the stock is ready to break out. More >

AI-Powered Medical Education Suite Cuts Costs, whilst Enhancing Clinical Skills Training for Future Doctors
Source: Streetwise Reports  (6/16/25)
Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) launched its enhanced medical education suite in Minnesota, showing strong reliability and providing schools with up to 40% cost savings. Read on to find out how AI-simulated patients are reshaping medical education and enhancing clinical skills at scale. More >

Healthcare Firm Uncovers AI Healthcare Growth Opportunity
Source: Streetwise Reports  (6/6/25)
Treatment.com AI Inc.'s (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) subsidiary Rocket Doctor was chosen by the Larta Institute to participate in its Bioscience and Healthcare Accelerator program. Read on to learn why one analyst says it is time to buy this company's stock. More >

Co. Poised to Begin Major New Bull Market
Source: Clive Maund  (5/23/25)
Technical Analyst Clive Maund explains why he thinks Algernon Pharmaceuticals Inc. (AGN:CSE; AGNPF:OTCQB; AGW0:XFRA) is an Immediate Strong Buy. More >

Centrally Positioned AI Co. Platform Designed To Transform Healthcare
Source: Clive Maund  (5/21/25)
Technical Analyst Clive Maund explains why he thinks now is an excellent time to buy or add to positions in Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA). More >

Biopharma Company Leverages AI-Powered Platform for Cancer Breakthroughs
Source: Streetwise Reports  (4/24/25)
Rakovina Therapeutics Inc. (RKV:TSX.V) announced its scientific advisor and collaborator Dr. Artem Cherkasov was recently recognized as a leader in AI-driven drug development. Find out which analysts recently initiated coverage on the company. More >

Two Use Cases for AI in Healthcare
Source: Streetwise Reports  (3/14/25)
In both, proprietary software platforms analyze heaps of data, but one focuses on genetics, the other neurology. Learn more about the companies behind the technology. More >

AI Stock in an Uptrend That Is Likely To Continue
Source: Clive Maund  (2/10/25)
Technical Analyst Clive Maund explains why he thinks Light AI Inc. (ALGO:CBOE) is an Immediate Strong Buy. More >

Tech Innovator Achieves Breakthrough Multi-Market Success
Source: Streetwise Reports  (1/15/25)
Clean technology company BioLargo Inc. (BLGO:OTCQX) announces it had a "widely successful" and "transformative" 2024 and is looking forward to more revenue growth in 2025. Read why one expert thinks investors should be doubling down on the stock. More >

AI Company Unlocks Breakthrough Medical Diagnostics Platform
Source: Streetwise Reports  (1/6/25)
One company being listed on Cboe Canada starting January 8 is using AI and smartphones to help patients get quick and accurate diagnosis of their sore throats, helping to battle microbial resistance that threatens the effectiveness of antibiotics worldwide. More >

Is This Centrally Positioned AI Healthcare Co. Set to Transform the Industry?
Source: Clive Maund  (12/20/24)
Technical Analyst Clive Maund explains why he thinks Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) offers potential upside to investors. More >

AI Accelerates Breakthroughs in Cancer Drug Discovery
Source: Streetwise Reports  (12/3/24)
Rakovina Therapeutics Inc. (RKV:TSX.V) is advancing cancer drug discovery with its Deep Docking AI platform. Read more about their recent developments and future plans. More >

Transformative Moves in Harm Reduction Expanding Market Reach with New Partnerships and Acquisitions
Source: Streetwise Reports  (11/15/24)
Safe Supply Streaming Co. Ltd (SPLY:CSE; SSPLF:OTCQB; QM4:FSE) recently announced significant developments within its portfolio company, Safety Strips, and a key acquisition. Learn more about how these strategic developments aim to enhance harm reduction efforts and expand market reach.

More >

AI Healthcare Co. With 'Bright' Outlook Closes Placement
Source: Streetwise Reports  (10/31/24)
Healthcare artificial intelligence (AI) company Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) has closed a non-brokered private placement for aggregate gross proceeds of CA$1.95 million. Find out why one analyst says the stock is a Strong Buy and worth going overweight on. More >

Is This AI Healthcare Stock Worth Being Overweight On?
Source: Clive Maund  (10/9/24)
Technical Analyst Clive Maund explains why he thinks Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) is a Strong Buy and worth being overweight on. More >

Healthcare Tech Firm and Leading University to Join Forces
Source: Streetwise Reports  (9/7/24)
The parties intend to develop artificial intelligence-backed solutions to a problem in healthcare, for expanded use throughout and beyond the United Kingdom. Find out why one analyst is bullish on this company and its proprietary platform. More >

AI Healthcare Co. Signs Partnership With Large Regional Health Plan
Source: Dr. Jonathan Aschoff  (8/9/24)
Ontrak Inc. (NASDAQ: OTRK) announced it had signed a two-year strategic partnership with a large, northeast regional health plan focused on the plan's New York State members. This development comes as the company continues to rebuild its client base following a significant customer loss in Q1 2024, noted a Roth MKM research note. More >

AI Healthcare Co. Creates AI Pharmacy Assistant
Source: Streetwise Reports  (8/2/24)
Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) announced it will roll out a new AI (artificial intelligence) Pharmacy Assistant to support pharmacists. One analyst says the company has positioned itself as a "central go-to resource." More >

AI Health Stock Heading Higher Expert Says
Source: Clive Maund  (7/2/24)
Technical Analyst Clive Maund gives an update on Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) as he believes "something is going on" and the stock may be heading higher. More >

Co. Expands Telehealth Contract to New State
Source: Streetwise Reports  (5/22/24)
Reliq Health Technologies Inc. announced that a large U.S. health group has expanded its contract with the telehealth company to cover facilities in a new state. Read why one analyst thinks the stock is a Buy. More >

AI Healthcare Stock Has Bullish Setup, Expert Says
Source: Clive Maund  (4/22/24)
Technical Analyst Clive Maund reviews Treatment.com AI's charts and the recent influx of news to explain why he believes it is a Strong Buy. More >